GlycoNex Announces Last Patient Dosed in Phase 3 Trial of SPD8, a Denosumab Biosimilar for Osteoporosis

Topline data expected in second quarter 2026 GlycoNex, Inc. (4168, hereinafter referred to as GNX), today announced that the last patient has received the final dose in its Phase 3 clinical study of SPD8, a biosimilar to denosumab for the treatment of osteoporosis. Developed in collaboration with Mitsubishi Gas Chemical (MGC), SPD8 is designed to […]

Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has entered into a collaboration with Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease. The partnership agreement will focus on Engineering, Differentiation, and Production (EDP) activities to advance

Equip Expo Breaks More Records

Deck: Nearly 30,000 landscapers, dealers, and manufacturers attended the 2025 trade show Equip Exposition, the international landscape, outdoor living, and equipment exposition, posted another year of record attendance with nearly 30,000 registered attendees and double-digit growth in both landscaper and dealer audiences. https://mma.prnewswire.com/media/2807920/Equip_Exposition_Floor_Image_to_go_with_press_release.jpg “Now in our fourth year as Equip, we continue to break records

Osisko Development Closes C$82.5 Million Private Placement

(TSX-V:ODV),(NYSE:ODV), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce the successful closing of its previously-announced oversubscribed private placement offering of 15,409,798 common shares of

KZ Provisioning Appoints Former NBA Executive Bri Rosas as CEO to Lead Next Phase of Growth in Professional & Collegiate Sports Performance Nutrition

Sports-focused culinary partner to pro teams in the NBA, NHL, and WNBA prepares to expand nationwide elevating athlete performance through sports nutrition KZ Provisioning, a leader in hospitality-driven sports performance and culinary innovation, today announced the appointment of Bri Rosas as its first Chief Executive Officer signaling a bold step forward in the company's mission

Erchonia Advances Multidisciplinary Clinical Laser Applications at 24th Annual Laser Expo

Global medical laser technology leader expands clinical education and introduces first dental specialty track in Greenville, South Carolina Erchonia Corporation, a global leader in low-level laser and light-based therapy, will showcase the latest advancements in multidisciplinary laser applications at its 2025 Laser Expo, November 6-8, 2025, in Greenville, South Carolina. The three-day event brings together

Osisko Development Closes C$82.5 Million Private Placement

Osisko Development Closes C$82.5 Million Private Placement GlobeNewswire October 29, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce the successful closing of its

Learning Ally Sponsors Nationwide Virtual Screening of Left Behind, a Documentary on the Fight for Dyslexia Equity

Free online access available October 24 – October 31 Learning Ally, a national nonprofit committed to unlocking the potential of students with learning differences, is proud to exclusively sponsor a nationwide virtual screening of Left Behind, a powerful new documentary directed by Anna Toomey. The film – praised by Anderson Cooper of CNN as “powerful…

Celebrating a Decade of Innovation and Excellence at NovoTech Patent Firm

This year, NovoTech Patent Firm proudly marked its 10-year anniversary-a decade dedicated to protecting innovation and empowering inventors worldwide. From our humble beginnings to becoming a trusted partner for both global corporations and dynamic startups, our journey has been fueled by passion and expertise. Over the past ten years, we've: — Handled approximately 3,700 patent

Redefining the future of transplant medicine at VCU Health

How nationally ranked Hume-Lee Transplant Center is giving more patients a second chance through innovation. Innovation isn't a buzzword at VCU Health Hume-Lee Transplant Center – it's the lifeblood of this nationally ranked program – one that gives more patients a second chance at life. https://mma.prnewswire.com/media/2805936/VCU_Health__David_Bruno.jpg “Our goal is not to follow what's next, but

Scroll to Top